MAK Capital reports 6.3% stake in ClearPoint Neuro (CLPT) via Schedule 13G/A

Rhea-AI Filing Summary

ClearPoint Neuro, Inc. disclosure: MAK Capital Fund LP, MAK Capital One LLC and Michael A. Kaufman report 1,901,489 shares of Common Stock beneficially owned, representing 6.3% of the class. The calculation is based on holdings as of 05/15/2026 and 29,989,563 shares outstanding as of May 7, 2026.

The filing identifies shared voting and dispositive power over the 1,901,489 shares and lists principal business addresses for the reporting persons.

Insights

Governance Analyst

MAK entities report a passive, but notable 6.3% stake with shared control.

MAK Fund, MAK Capital and Michael A. Kaufman disclose beneficial ownership of 1,901,489 shares as of 05/15/2026. The filing lists shared voting and dispositive power rather than sole control, consistent with pooled or managed positions.

Implications depend on future filings: any change to sole voting power or additional acquisitions would be disclosed in subsequent schedules. Timing and cash‑flow treatment are not stated in the excerpt.

Compliance Counsel

Form and attribution follow Schedule 13G/A conventions; signatures provided by the managing member.

The document names the reporting persons, cites citizenship and business addresses, and attaches a calculation tying holdings to the issuer's Form 10-Q outstanding share count. Signatures by Michael A. Kaufman appear dated 05/15/2026.

Future changes in ownership or voting power would require amended filings under applicable rules; current filing shows no sole dispositive power.

Key Figures

Beneficial ownership: 1,901,489 shares Percent of class: 6.3% Shares outstanding: 29,989,563 shares

3 metrics

Beneficial ownership 1,901,489 shares Beneficially owned as of <date>05/15/2026</date>

Percent of class 6.3% Calculated using 29,989,563 shares outstanding as of <date>May 7, 2026</date>

Shares outstanding 29,989,563 shares Outstanding as of <date>May 7, 2026</date> per issuer Form 10-Q

Key Terms

Schedule 13G/A, Beneficially owned, Shared dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 1 and header identifying the filing type"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned regulatory

"Amount beneficially owned: 1,901,489 (b) Percent of class: 6.3%"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Shared dispositive power regulatory

"Shared Dispositive Power 1,901,489.00 reported in ownership table"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 05:13 PM Learn about SEC filing dates

FAQ

What stake does MAK Capital report in ClearPoint Neuro (CLPT)?

MAK Fund, MAK Capital One LLC and Michael A. Kaufman report 1,901,489 shares, equal to 6.3% of Common Stock based on 29,989,563 shares outstanding as of May 7, 2026. The ownership figure is as of 05/15/2026.

How is voting and disposition power reported for the 1,901,489 shares?

The filing states 0 sole voting/dispositive power and 1,901,489 shared voting and dispositive power, indicating the reporting persons share control over voting and disposition of these shares rather than holding sole authority.

Which entities and individuals filed this Schedule 13G/A for CLPT?

The Schedule 13G/A is filed by MAK Capital Fund LP, MAK Capital One L.L.C., and Michael A. Kaufman. Principal addresses for the entities and for Mr. Kaufman are provided in the filing.

What dates anchor the ownership and outstanding share counts in the filing?

The beneficial ownership count is stated as of 05/15/2026. The outstanding share total, 29,989,563 shares, is cited as of May 7, 2026 and is referenced to the issuer's Form 10‑Q filed on May 13, 2026.

Does the filing indicate any change in control or sole authority over CLPT shares?

No. The filing explicitly reports no sole voting or dispositional power and instead records shared voting and shared dispositive power over the 1,901,489 shares; it does not state any change in control.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

ClearPoint Neuro, Inc.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

18507C103

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 18507C103

1

Names of Reporting Persons

MAK Capital Fund LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

BERMUDA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,901,489.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,901,489.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,901,489.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.3 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: The calculation is based upon 1,901,489 shares of Common Stock beneficially owned as of 05/15/2026 and a total of 29,989,563 shares of Common Stock, $0.01 par value per share, outstanding as of May 7, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 13, 2026.

SCHEDULE 13G

CUSIP Number(s): 18507C103

1

Names of Reporting Persons

MAK CAPITAL ONE LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,901,489.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,901,489.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,901,489.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.3 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: The calculation is based upon 1,901,489 shares of Common Stock beneficially owned as of 05/15/2026 and a total of 29,989,563 shares of Common Stock, $0.01 par value per share, outstanding as of May 7, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 13, 2026.

SCHEDULE 13G

CUSIP Number(s): 18507C103

1

Names of Reporting Persons

Kaufman Michael A

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,901,489.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,901,489.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,901,489.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.3 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The calculation is based upon 1,901,489 shares of Common Stock beneficially owned as of 05/15/2026 and a total of 29,989,563 shares of Common Stock, $0.01 par value per share, outstanding as of May 7, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 13, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ClearPoint Neuro, Inc.
(b)	Address of issuer's principal executive offices: 120 S. SIERRA AVENUE, SOLANA BEACH, CALIFORNIA, 92075.
Item 2.
(a)	Name of person filing: This Schedule 13G/A is being filed by: i. MAK Capital Fund LP ("MAK Fund") ii. MAK Capital One L.L.C. ("MAK Capital"); and iii. Michael A. Kaufman ("Mr. Kaufman," and collectively with MAK Fund and MAK Capital, the "Reporting Persons")
(b)	Address or principal business office or, if none, residence: The principal business address of (i) MAK Fund is c/o Wakefield Quin, Victoria Place, 31 Victoria Street, Bermuda; and (ii) MAK Capital and Mr. Kaufman is 590 Madison Avenue, 31st Floor, New York, NY 10022.
(c)	Citizenship: MAK Capital Fund LP is a Bermuda limited partnership. MAK Capital One L.L.C. is a Delaware limited liability company. Mr. Kaufman is a United States citizen.
(d)	Title of class of securities: Common Stock, $0.01 par value per share
(e)	CUSIP No.: 18507C103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,901,489
(b)	Percent of class: 6.3% The calculation is based upon 1,901,489 shares of Common Stock beneficially owned as of 05/15/2026 and a total of 29,989,563 shares of Common Stock, $0.01 par value per share, outstanding as of May 7, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 13, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 1,901,489
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 1,901,489
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

MAK Capital Fund LP

Signature:	/s/ Michael A. Kaufman
Name/Title:	Managing Member
Date:	05/15/2026

MAK CAPITAL ONE LLC

Signature:	/s/ Michael A. Kaufman
Name/Title:	Managing Member
Date:	05/15/2026

Kaufman Michael A

Signature:	/s/ Michael A. Kaufman
Name/Title:	Michael A. Kaufman
Date:	05/15/2026